Naofucong mitigates amyloid-β deposition and cognitive deficits by enhancing insulin-degrading enzyme expression and inhibiting BACE through MAPK pathway inhibition

Brain Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles